应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INSM Insmed
休市中 04-17 16:00:00 EDT
72.65
+2.45
+3.49%
盘后
71.50
-1.15
-1.58%
19:14 EDT
最高
72.67
最低
69.86
成交量
150.09万
今开
69.86
昨收
70.20
日振幅
4.00%
总市值
131.50亿
流通市值
120.89亿
总股本
1.81亿
成交额
1.08亿
换手率
0.90%
流通股本
1.66亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Insmed Incorporated4月17日成交额为1.08亿美元
市场透视 · 04-18
Insmed Incorporated4月17日成交额为1.08亿美元
Insmed Incorporated4月16日成交额为1.07亿美元
市场透视 · 04-17
Insmed Incorporated4月16日成交额为1.07亿美元
Insmed Incorporated4月14日成交额为1.68亿美元
市场透视 · 04-15
Insmed Incorporated4月14日成交额为1.68亿美元
Insmed Incorporated4月11日成交额为1.23亿美元
市场透视 · 04-12
Insmed Incorporated4月11日成交额为1.23亿美元
Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。
金融界 · 02-25
Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。
Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%
市场透视 · 02-23
Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%
Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。
金融界 · 02-21
Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。
异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌
异动解读 · 02-20
异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌
Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期
财报速递 · 02-20
Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期
小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。
金融界 · 02-07
小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。
大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。
金融界 · 02-06
大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。
Insmed Incorporated盘中异动 股价大涨5.09%
市场透视 · 01-21
Insmed Incorporated盘中异动 股价大涨5.09%
特朗普2.0时代即将开启,投资机会如何掘金?
招商基金 · 01-20
特朗普2.0时代即将开启,投资机会如何掘金?
Insmed Incorporated盘中异动 快速上涨5.00%
市场透视 · 01-13
Insmed Incorporated盘中异动 快速上涨5.00%
Insmed Incorporated盘中异动 急速下挫5.74%
市场透视 · 01-10
Insmed Incorporated盘中异动 急速下挫5.74%
Insmed Incorporated盘中异动 下午盘急速下跌5.00%
市场透视 · 01-06
Insmed Incorporated盘中异动 下午盘急速下跌5.00%
2025年生物科技股有望回暖,高盛看好Insmed与传奇生物
老虎资讯综合 · 2024-12-30
2025年生物科技股有望回暖,高盛看好Insmed与传奇生物
Insmed Incorporated盘中异动 下午盘快速下挫5.05%报70.12美元
市场透视 · 2024-12-18
Insmed Incorporated盘中异动 下午盘快速下挫5.05%报70.12美元
Insmed Incorporated盘中异动 早盘快速上涨5.06%报69.98美元
市场透视 · 2024-11-19
Insmed Incorporated盘中异动 早盘快速上涨5.06%报69.98美元
Insmed Incorporated盘中异动 早盘股价大跌5.08%
市场透视 · 2024-11-15
Insmed Incorporated盘中异动 早盘股价大跌5.08%
加载更多
公司概况
公司名称:
Insmed
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。
发行价格:
--
{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":72.65,"timestamp":1744920000000,"preClose":70.2,"halted":0,"volume":1500918,"hourTrading":{"tag":"盘后","latestPrice":71.5,"preClose":72.65,"latestTime":"19:14 EDT","volume":48723,"amount":3536115.69,"timestamp":1744931658215},"delay":0,"floatShares":166405173,"shares":180999350,"eps":-5.570319,"marketStatus":"休市中","change":2.45,"latestTime":"04-17 16:00:00 EDT","open":69.86,"high":72.67,"low":69.86,"amount":107791659.147372,"amplitude":0.040028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.570319,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":959832000000,"exchange":"NASDAQ","adjPreClose":70.2,"preHourTrading":{"tag":"盘前","latestPrice":70.2,"preClose":70.2,"latestTime":"08:02 EDT","volume":15,"amount":1063.58985,"timestamp":1744891356108},"postHourTrading":{"tag":"盘后","latestPrice":71.5,"preClose":72.65,"latestTime":"19:14 EDT","volume":48723,"amount":3536115.69,"timestamp":1744931658215},"volumeRatio":0.7094315978444878,"impliedVol":0.7775,"impliedVolPercentile":0.8526},"requestUrl":"/m/hq/s/INSM","defaultTab":"news","newsList":[{"id":"2528704043","title":"Insmed Incorporated4月17日成交额为1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528704043?lang=zh_cn&edition=full","pubTime":"2025-04-18 09:44","pubTimestamp":1744940681,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日,Insmed Incorporated成交额为1.08亿美元,成交额较昨日增加0.64%,当日成交量为150.11万股。Insmed Incorporated于2025年4月17日涨3.49%,报72.65美元,该股过去5个交易日涨12.1%,年初至今涨5.23%,过去60日跌7.39%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-17|1.08亿|0.64%|150.11万|#|2025-04-16|1.07亿|-2.81%|152.95万|#|2025-04-15|1.10亿|-34.31%|156.29万|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094450a45d43be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094450a45d43be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","INSM","BK4139"],"gpt_icon":0},{"id":"2528368782","title":"Insmed Incorporated4月16日成交额为1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528368782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528368782?lang=zh_cn&edition=full","pubTime":"2025-04-17 09:42","pubTimestamp":1744854146,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日,Insmed Incorporated成交额为1.07亿美元,成交额较昨日减少2.81%,当日成交量为152.95万股。Insmed Incorporated于2025年4月16日跌1.22%,报70.2美元,该股过去5个交易日涨3.92%,年初至今涨1.68%,过去60日跌8.53%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-16|1.07亿|-2.81%|152.95万|#|2025-04-15|1.10亿|-34.31%|156.29万|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094235a6bd4327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094235a6bd4327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2527086131","title":"Insmed Incorporated4月14日成交额为1.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527086131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527086131?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:38","pubTimestamp":1744681101,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日,Insmed Incorporated成交额为1.68亿美元,成交额较昨日增加36.48%,当日成交量为238.60万股。Insmed Incorporated于2025年4月14日涨3.59%,报71.03美元,该股过去5个交易日涨4.32%,年初至今涨2.88%,过去60日跌2.36%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|#|2025-04-09|3.31亿|78.63%|507.17万|#|2025-04-08|1.86亿|-24.75%|282.51万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093827a6baaa2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093827a6baaa2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0053671581.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","INSM"],"gpt_icon":0},{"id":"2526272756","title":"Insmed Incorporated4月11日成交额为1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526272756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2526272756?lang=zh_cn&edition=full","pubTime":"2025-04-12 09:40","pubTimestamp":1744422045,"startTime":"0","endTime":"0","summary":"美东时间2025年4月11日,Insmed Incorporated成交额为1.23亿美元,成交额较昨日减少41.49%,当日成交量为182.34万股。Insmed Incorporated于2025年4月11日涨5.8%,报68.57美元,该股过去5个交易日跌0.88%,年初至今跌0.68%,过去60日跌2.32%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|#|2025-04-09|3.31亿|78.63%|507.17万|#|2025-04-08|1.86亿|-24.75%|282.51万|#|2025-04-07|2.47亿|13.40%|366.68万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412094053a6b8599a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412094053a6b8599a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2514113720","title":"Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514113720","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514113720?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:23","pubTimestamp":1740500610,"startTime":"0","endTime":"0","summary":"Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26002348385754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2513875615","title":"Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513875615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513875615?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326449,"startTime":"0","endTime":"0","summary":"2月24日,Insmed Incorporated公布财报,公告显示公司2024财年净利润为-9.14亿美元,同比减少21.87%;其中营业收入为3.64亿美元,同比增加19.34%,每股基本收益为-5.57美元。从资产负债表来看,Insmed Incorporated总负债17.40亿美元,其中短期债务16.50百万美元,资产负债比为1.17,流动比率为5.45。机构评级:截至2025年2月24日,当前有15家机构对Insmed Incorporated目标价做出预测,其中目标均价为96.93美元,其中最低目标价为89.00美元,最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000118a250ce02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000118a250ce02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2513691213","title":"Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513691213","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513691213?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:41","pubTimestamp":1740159669,"startTime":"0","endTime":"0","summary":"Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22014148321070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"1119035536","title":"异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1119035536","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119035536?lang=zh_cn&edition=full","pubTime":"2025-02-20 22:37","pubTimestamp":1740062235,"startTime":"0","endTime":"0","summary":"在今日盘中交易中,生物制药公司Insmed股价大跌5.11%,引发了市场广泛关注。据分析,这与公司2024年第四季度财报表现不佳有很大关系。\n\n具体来看,Insmed上一季度销售额虽然达到1.0444亿美元、高于预期,但同比增长仅为24.79%,增速明显放缓。更为重要的是,Insmed当季每股亏损高达1.32美元,远高于分析师预期的1.17美元亏损。\n\n营收增长放缓加之亏损扩大,令投资者对Insmed的业务前景和盈利能力产生质疑,从而引发公司股价在盘中大幅下跌。Insmed面临着业绩增长乏力、成本控制不佳等一系列问题,当务之急是尽快扭转局面、实现盈利,从而重拾投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSM"],"gpt_icon":0},{"id":"1148282852","title":"Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1148282852","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148282852?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:09","pubTimestamp":1740053345,"startTime":"0","endTime":"0","summary":"Insmed 报告了季度每股亏损$,比分析师共识预期的$低了12.82%。这一亏损相比去年同期的每股亏损$减少了3.13%。公司报告的季度销售额为$1.0444亿,高于分析师共识预期的$1.0179亿,增长了2.60%。以上内容来自Benzinga Earnings专栏,原文如下:$Insmed$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 12.82 percent. This is a 3.13 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $104.44 million which beat the analyst consensus estimate of $101.79 million by 2.60 percent. This is a 24.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSM"],"gpt_icon":1},{"id":"2509774987","title":"小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509774987?lang=zh_cn&edition=full","pubTime":"2025-02-08 05:21","pubTimestamp":1738963318,"startTime":"0","endTime":"0","summary":"小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08052148031920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2509274305","title":"大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509274305","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509274305?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:22","pubTimestamp":1738851741,"startTime":"0","endTime":"0","summary":"大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/06222248001920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2505205840","title":"Insmed Incorporated盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505205840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505205840?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:20","pubTimestamp":1737476447,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时20分,Insmed Incorporated股票出现异动,股价急速上涨5.09%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为1.61%。其相关个股中,Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为757.13%、475.49%、182.30%,振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.,振幅分别为96.32%、41.33%、38.48%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122002047986e474b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122002047986e474b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","INSM","BK4139"],"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启,投资机会如何掘金?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启,有哪些投资机会可以布局?值得一提的是,科技股在特朗普任期内表现尤为突出,成为推动美股上涨的主要力量。在特朗普第一个任期内,美元整体表现相对弱势。4年任期内,美元指数累计下跌了10.53%。而纵观全球市场,在特朗普上一任期内,恒生科技指数涨幅超过147%,表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUR","GMAB","NBIX","FCNCA","BPOP","TER","RADX","TTEK","TPG","EQIX","SNPS","STLD","TSYW.SI","SRPT","CASY","CSCO","EA","ARGX","LOGI","ILMN","COO","IDXX","MRVL","LSTR","NDSN","DOCU","QCOM","ZM","DLTR","RGLD","CDW","REG","AAPL","WWD","ZS","CHRD","SWKS","BIIB","CME","EXAS","NTES","ASML","AFRM","ON","ODFL","HON","PARA","HBAN","BK4086","BRKR","NWSA","CHDN","POOL","RKLB","HTHT","AMAT","KDP","MTSI","HQY","ROKU","ERIE","HOLX","LIN","MKSI","AGNC","NXPI","SAIA","BKNG","SFM","TXN","WDC","DASH","GEHC","NQmain","LSCC","CEG","META","CYBR","ICLR","ALNY","AXON","NTNX","BK4588","DKNG",".IXIC","KHC","EXE","NFLX","MTCH","INTU","DPZ","LNT","NVDA","PEP","WBA","RIVN","ENTG","APA","ESLT","PAA","CTSH","LKQ","BPMC","CHRW","AMZN","CSGP","CHTR","MMYT","HSIC","ROP","FRPT","MARA","PLTR","TLN","TTWO","AMD","EXPE","BK4550","BK4534","MNDY","ISRG","SOFI","Z","INSM","MCHP","MNST","SSNC","SMCI","HOOD","CDNS","QXO","PTC","PODD","TQQQ","GNTX","DUOL","SEIC","GTLB","CZR","CG","CSWI","NTRA","ERIC","LU0053671581.USD","NTAP","CCEP","BK4593","CTAS","RGEN","JKHY","NICE","SIRI","TCOM","CINF","ADI","FWONK","GRAB","NVMI","PAYX","GOOGL","COIN","GILD","QQQ","RPRX","USJW.SI","TTD","MELI","CPRT","WTFC","JD","LECO","LNW","PDD","NTRS","NVIW.SI","MDLZ","LU0757428866.USD","ARM","CRWD","STX","OTEX","CSX","AVGO","EWBC","MPWR","WYNN","USAW.SI","TSCO","LULU","MDB","FTAI","FOXA","SQQQ","MANH","NDAQ","TROW","ADBE","ROST","LPLA","FSLR","BK4585","MKTX","EVRG","MSFT","QLD","RVMD","GLPI","LU1815336091.USD","CWST","ORLY","AEP","DSGX","PCAR","CBSH","TEAM","FAST","ITCI","DOX","LI","AMGN","JBHT","TSLA","TSEM","COST","REGN","ANSS","EBAY","GEN","SBAC","TMUS","TRMB","MIDD","LAMR","ONC","AKAM","BK4581","COKE","PCVX","QRVO","INCY","PFG","FTNT","BK4561","DDOG","ULTA","BKR","HLNE","PNFP","MEDP","PCTY","ROIV","TECH","RYAAY","QID","ALAB","AAL","CHKP","LU2065731478.USD","ALGN","FSV","BMRN","CPB","MNQmain","OLED","AAON","FER","FFIV","FOX","INTC","MRNA","SBUX","HST","FYBR","BSY","OKTA","CFLT","ADSK","PSQ","ENPH","TW","AZN"],"gpt_icon":1},{"id":"2503963535","title":"Insmed Incorporated盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503963535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503963535?lang=zh_cn&edition=full","pubTime":"2025-01-14 01:34","pubTimestamp":1736789673,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日01时34分,Insmed Incorporated股票出现波动,股价大幅上涨5.00%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃,换手率分别为12627.63%、7253.34%、652.28%,振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为336.09%、221.73%、201.86%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114013433960270a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114013433960270a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","INSM","LU0889565916.HKD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2502860219","title":"Insmed Incorporated盘中异动 急速下挫5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502860219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502860219?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:31","pubTimestamp":1736519498,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分,Insmed Incorporated股票出现异动,股价快速下跌5.74%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.涨幅较大,Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃,换手率分别为900.38%、131.25%、104.68%,振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Engene Holdings Inc.,振幅分别为15.25%、10.00%、7.90%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223138aba60260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223138aba60260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","INSM","LU0109394709.USD","BK4139","LU0320765992.SGD","LU0053671581.USD"],"gpt_icon":0},{"id":"2501264085","title":"Insmed Incorporated盘中异动 下午盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501264085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501264085?lang=zh_cn&edition=full","pubTime":"2025-01-07 04:06","pubTimestamp":1736193976,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日04时06分,Insmed Incorporated股票出现异动,股价急速下挫5.00%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Scisparc Ltd.、Geovax Labs Inc C/Wts 29/09/2025、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为1707.44%、396.36%、199.23%,振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为176.15%、106.67%、92.16%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010704061795faac59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010704061795faac59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","INSM"],"gpt_icon":0},{"id":"1145945675","title":"2025年生物科技股有望回暖,高盛看好Insmed与传奇生物","url":"https://stock-news.laohu8.com/highlight/detail?id=1145945675","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145945675?lang=zh_cn&edition=full","pubTime":"2024-12-30 09:47","pubTimestamp":1735523264,"startTime":"0","endTime":"0","summary":"2025年生物科技股趋势有望回升,谨慎选股仍是明智之举经历了几年的糟糕表现后,2025年的生物科技股趋势可能会有所回暖,但专家仍建议投资者要谨慎选择,特别是关注那些最具创新性的公司。$高盛$看好$Insmed$和$传奇生物$在具体公司方面,高盛分析师对Insmed表现出较为乐观的态度。她指出,Legend正在扩展其Carvykti药物的适应症,并预计2025年和2026年将出现大幅增长。市场的潜力与风险$摩根士丹利$分析师也在2025年展望中将Legend生物列为重点关注公司之一。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","INSM"],"gpt_icon":1},{"id":"2492153787","title":"Insmed Incorporated盘中异动 下午盘快速下挫5.05%报70.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492153787?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:05","pubTimestamp":1734552352,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时05分,Insmed Incorporated股票出现异动,股价大幅跳水5.05%。截至发稿,该股报70.12美元/股,成交量92.5506万股,换手率0.52%,振幅5.74%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为2.02%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040553984cb7d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040553984cb7d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","INSM","LU0889565916.HKD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2484928253","title":"Insmed Incorporated盘中异动 早盘快速上涨5.06%报69.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484928253?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:33","pubTimestamp":1732026780,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时33分,Insmed Incorporated股票出现波动,股价大幅拉升5.06%。截至发稿,该股报69.98美元/股,成交量9.9791万股,换手率0.06%,振幅2.99%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为0.81%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922330198e437dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922330198e437dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","LU0109394709.USD","INSM","LU0053671581.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2483059513","title":"Insmed Incorporated盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483059513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483059513?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:35","pubTimestamp":1731684957,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时35分,Insmed Incorporated股票出现波动,股价快速下挫5.08%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为3.20%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大,Tc Biopharm Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为3377.90%、486.29%、305.92%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为129.73%、118.31%、110.59%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523355798e42fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523355798e42fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":0.121},{"period":"1month","weight":-0.0564},{"period":"3month","weight":0.0019},{"period":"6month","weight":-0.0254},{"period":"1year","weight":1.775},{"period":"ytd","weight":0.0523}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.470588,"avgChangeRate":0.071463},{"month":2,"riseRate":0.411765,"avgChangeRate":0.079066},{"month":3,"riseRate":0.371429,"avgChangeRate":-0.053836},{"month":4,"riseRate":0.4,"avgChangeRate":0.047913},{"month":5,"riseRate":0.411765,"avgChangeRate":0.070481},{"month":6,"riseRate":0.529412,"avgChangeRate":0.014908},{"month":7,"riseRate":0.470588,"avgChangeRate":0.002456},{"month":8,"riseRate":0.382353,"avgChangeRate":-0.030186},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031309},{"month":10,"riseRate":0.411765,"avgChangeRate":-0.025331},{"month":11,"riseRate":0.647059,"avgChangeRate":0.105304},{"month":12,"riseRate":0.470588,"avgChangeRate":0.046817}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}